Inactive Instrument

News GW Pharmaceuticals plc London S.E.

Equities

GB0030544687

End-of-day quote London S.E. Other stock markets
- ^GBX	-

2021	Jazz Pharmaceuticals : U.S. FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav	RE
2021	Sector Update: Health Care Stocks Steady Premarket Tuesday	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fitch Affirms Jazz's IDR at 'BB-'; Outlook Positive	23-04-06	AQ
Former President of GW Pharmaceuticals USA Joins Lexaria Bioscience as Strategic Advisor	23-01-23	AQ
Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing	22-03-28	AQ
JAZZ PHARMACEUTICALS ANNOUNCES FULL YEAR AND FOURTH QUARTER 2021 FINANCIAL RESULTS	22-03-02	AQ
Jazz Pharmaceuticals : U.S. FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav	21-08-12	RE
Sector Update: Health Care Stocks Steady Premarket Tuesday	21-08-10	MT
Jazz Pharmaceuticals : GW Pharmaceuticals Bags UK Nod for New Use of Cannabis-Based Seizure Drug	21-08-10	MT
Jazz Pharmaceuticals' : Subsidiary Gets UK Approval for Epidyolex in Patients With Tuberous Sclerosis Complex-Related Seizures	21-08-10	MT
Gw Pharmaceuticals Receives Approval for Epidyolex (Cannabidiol) from the MHRA for the Treatment of Seizures Associated with Tuberous Sclerosis Complex	21-08-10	CI
Jazz Pharmaceuticals : Updates 2021 Full-Year Guidance Following GW Pharmaceuticals Buy	21-06-17	MT
Jazz Pharmaceuticals : Updates FY2021 Outlook to Reflect GW Pharmaceuticals Purchase	21-06-17	MT
Palla Pharma : Names New CEO; Shares Soar 18%	21-05-26	MT
Alkame : PAO Group, Inc.'s CBD Nutraceuticals Expected To Deliver Revenue-Generating Catalyst in 2021; New Partnerships Expand Its Long-Term CBD Pharmaceutical Programs	21-05-12	AQ
GW Pharmaceuticals plc(NasdaqGM:GWPH) dropped from S&P Global BMI Index	21-05-10	CI
PAO Group, With A CRO On Its Side, Could Deliver Its First CBD-Based Therapeutic By Year's End	21-05-06	AQ
GW PHARMACEUTICALS PLC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	21-05-05	AQ
Jazz Pharmaceuticals : Completes Purchase of GW Pharmaceuticals	21-05-05	MT
GW Pharmaceuticals : Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc	21-05-05	PR
GW Pharmaceuticals plc(NasdaqGM:GWPH) dropped from NASDAQ Composite Index	21-05-04	CI
Jazz Pharmaceuticals plc completed the acquisition of GW Pharmaceuticals plc.	21-05-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News GW Pharmaceuticals plc London S.E.

Equities

GB0030544687

Summary

Filters